UK markets close in 7 hours 12 minutes

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
116.96+1.34 (+1.16%)
At close: 04:00PM EDT
114.74 -2.22 (-1.90%)
After hours: 04:21PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,243,336
1,243,336
933,013
701,887
540,099
Cost of revenue
150,343
150,343
139,989
97,049
63,382
Gross profit
1,092,993
1,092,993
793,024
604,838
476,717
Operating expenses
Research development
877,387
877,387
877,090
771,182
722,343
Selling general and administrative
481,871
481,871
451,421
282,660
317,875
Total operating expenses
1,360,817
1,360,817
1,329,225
1,054,548
1,040,880
Operating income or loss
-267,824
-267,824
-536,201
-449,710
-564,163
Interest expense
22,010
22,010
53,248
63,525
59,947
Total other income/expenses net
-316,233
-316,233
-128,237
93,776
68,075
Income before tax
-520,098
-520,098
-689,963
-418,948
-553,065
Income tax expense
15,879
15,879
13,525
-168
1,063
Income from continuing operations
-535,977
-535,977
-703,488
-418,780
-554,128
Net income
-535,977
-535,977
-703,488
-418,780
-554,128
Net income available to common shareholders
-535,977
-535,977
-703,488
-418,780
-554,128
Basic EPS
-7.80
-5.80
-8.03
-5.15
-7.11
Diluted EPS
-7.80
-5.80
-8.03
-5.15
-7.11
Basic average shares
88,417
92,398
87,559
81,262
77,956
Diluted average shares
88,417
92,398
87,559
81,262
77,956